entertainment -WSS

entertainment

author：fashion 2025-09-29 19:58:08 - browse：69845

Intellia Therapeutics said Sunday that the first 10 patients to receive a CRISPR-based treatment for hereditary angioedema, a genetic disease, saw their swelling attacks — the condition’s hallmark symptom — virtually eliminated for an average of 20 months and counting.

The attacks were reduced by an average of 98%. One patient has remained attack-free for 26 months. Two patients who suffered particularly frequent attacks, experiencing 14 and 16.8 per month, respectively, have now gone more than 20 months since their last attack.

No patient has had an attack in the last 11 months of follow-up, according to the data presented at the European Academy of Allergy and Clinical Immunology Congress. All side effects were either grade 1 or 2 on a 5-grade scale.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Eating disorder hotline's move to chatbot carried cost for volunteers

leisure time

hotspot

WSS

Zyn nicotine pouches become unlikely player in latest culture war

Tuskegee Airman Raymond Cassagnol dies at 102

Zyn nicotine pouches become unlikely player in latest culture war

The simple reason for the increase in autism diagnosis

Merck, Johnson & Johnson CEOs will testify on high drug prices

Ukrainian soldiers say they owe lives to US

focus

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

focus

What does generative AI mean for health care? We asked experts

GOP hopefuls to address prominent, controversial group questioning what's taught in schools

Moonlake's readout produced a cash windfall. Risks remain

Investment in vaccine development is lagging, report finds

Apple is now the first public company to be valued at $3 trillion

Boston competes with Raleigh

Trump demands the U.S. pay no more for drugs than other countries … again

Medicare drug price negotiation legal challenge met with skepticism

Virginia high school admissions case could be legal follow

New lesbian bars spark hope amid disappearing LGBTQ+ spaces

Wikipedia

Lilly’s obesity pill cuts 15% of weight at highest dose in mid

Syphilis numbers in the United States reach record heights

Tuskegee Airman Raymond Cassagnol dies at 102

Health Care Service Corp to buy Cigna Medicare Advantage plans

ADA: All diabetes patients should be screened for liver condition

GOP hopefuls to address prominent, controversial group questioning what's taught in schools

entertainment

leisure time

hotspot

entertainment